Methronidazole Other names: Metronidazole

Chemical formula: C₆H₉N₃O₃  Molecular mass: 171.154 g/mol  PubChem compound: 4173

Therapeutic indications

Methronidazole is indicated for:

Anaerobic infections

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Anaerobic bacterial infection and additionally Metronidazole susceptible species

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Amoebiasis by Entamoeba histolytica

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Amebic infection and additionally Entamoeba histolytica

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Giardiasis

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Giardiasis and additionally Giardia lamblia

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Prophylaxis against postoperative infections caused by anaerobic bacteria

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

Preventive procedure and additionally
Anaerobic bacterial infection and additionally Metronidazole susceptible species

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Urogenital trichomoniasis

Population group: only adolescents (12 years - 18 years old) , adults (18 years old or older)

at least one of
Urogenital infection by Trichomonas vaginalis
Trichomonas vaginalis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Bacterial vaginosis

Population group: only adolescents (12 years - 18 years old)

Bacterial vaginosis and additionally Metronidazole susceptible species

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Anaerobic infections

Population group: only newborns (0 - 40 days old) , infants (40 days - 1 year old) , children (1 year - 12 years old)

Anaerobic bacterial infection and additionally Metronidazole susceptible species

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Urogenital trichomoniasis

Population group: only children (1 year - 12 years old)

at least one of
Urogenital infection by Trichomonas vaginalis
Trichomonas vaginalis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Giardiasis

Population group: only children (1 year - 12 years old)

Giardiasis and additionally Giardia lamblia

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Eradication of Helicobacter pylori

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old)

at least one of
Helicobacter eradication therapy
Helicobacter pylori

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Amoebiasis by Entamoeba histolytica

Population group: only children (1 year - 12 years old)

Amebic infection and additionally Entamoeba histolytica

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Prophylaxis against postoperative infections caused by anaerobic bacteria

Population group: only newborns (0 - 40 days old) , infants (40 days - 1 year old) , children (1 year - 12 years old)

Preventive procedure and additionally
Anaerobic bacterial infection and additionally Metronidazole susceptible species

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Inflammatory papulo-pustules rosacea

Population group: only adults (18 years old or older)

For the topical treatment of inflammatory papulo-pustules rosacea related.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Periodontitis

Population group: only adults (18 years old or older)

Periodontitis and additionally Metronidazole susceptible species

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Methronidazole is contraindicated in the following cases:

Pregnancy

Pregnancy

Lactation

Lactation

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2017: METRONIDAZOLE Solution for infusion
Structured Product Labeling (SPL) 2020: NORITATE Cream
Summary of Product Characteristics (SPC) 2015: ROSICED Cream
Summary of Product Characteristics (SPC) 2018: METRONIDAZOLE Film-coated tablet
Structured Product Labeling (SPL/PLR) 2019: METROGEL Gel
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈